Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-11

Clinical Trial Update: Coenzyme Q10 in Adult-Onset Ataxia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of Coenzyme Q10 in adults with sporadic ataxia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coenzyme Q10 (Coenzyme Q10)

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Sporadic Ataxia | Phase 1 | Status: COMPLETED